AI assistant
Sending…
Tempest Therapeutics, Inc. — Director's Dealing 2012
Jun 11, 2012
34632_dirs_2012-06-11_b07f994d-b158-4356-af3d-ac33f66b5054.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: OvaScience, Inc. (OVAS)
CIK: 0001544227
Period of Report: 2012-06-11
Reporting Person: CAPELLO JEFFREY D (Director)
More from Tempest Therapeutics, Inc.
Transaction in Own Shares
2026
Jul 8
Capital/Financing Update
2026
Jun 26
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 22
Proxy Solicitation & Information Statement
2026
Jun 8
Board/Management Information
2026
Jun 4
Regulatory Filings
2026
Jun 1
Board/Management Information
2026
May 29
Delisting Announcement
2026
May 22
Board/Management Information
2026
May 22
Interim / Quarterly Report
2026
May 14